Agilon Health’s (AGL) Sell (E+) Rating Reiterated at Weiss Ratings

Weiss Ratings restated their sell (e+) rating on shares of Agilon Health (NYSE:AGL) in a report issued on Friday,Weiss Ratings reports.

AGL has been the topic of several other reports. Sanford C. Bernstein reissued a “market perform” rating and issued a $1.40 target price (down from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Jefferies Financial Group decreased their target price on shares of Agilon Health from $2.40 to $1.10 and set a “hold” rating on the stock in a report on Friday, August 15th. Robert W. Baird decreased their target price on shares of Agilon Health from $5.00 to $1.00 and set a “neutral” rating on the stock in a report on Thursday, August 14th. Zacks Research raised shares of Agilon Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 21st. Finally, Evercore ISI decreased their target price on shares of Agilon Health from $5.00 to $3.00 and set an “in-line” rating on the stock in a report on Wednesday, July 9th. Four investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Agilon Health currently has an average rating of “Hold” and a consensus price target of $2.81.

Agilon Health Stock Performance

NYSE:AGL opened at $0.97 on Friday. Agilon Health has a 52 week low of $0.71 and a 52 week high of $6.08. The firm has a market cap of $400.33 million, a price-to-earnings ratio of -1.25 and a beta of 0.07. The firm’s 50-day simple moving average is $1.12 and its 200 day simple moving average is $2.10.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the business posted ($0.07) earnings per share. Agilon Health’s revenue was down 5.9% compared to the same quarter last year. Sell-side analysts anticipate that Agilon Health will post -0.59 EPS for the current year.

Institutional Investors Weigh In On Agilon Health

A number of hedge funds have recently made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC boosted its position in Agilon Health by 21.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company’s stock worth $432,000 after buying an additional 17,866 shares during the period. KBC Group NV acquired a new stake in Agilon Health during the 1st quarter worth approximately $70,000. Teacher Retirement System of Texas acquired a new stake in Agilon Health during the 1st quarter worth approximately $196,000. Bank of New York Mellon Corp boosted its position in Agilon Health by 4.3% during the 1st quarter. Bank of New York Mellon Corp now owns 807,761 shares of the company’s stock worth $3,498,000 after buying an additional 32,959 shares during the period. Finally, Nisa Investment Advisors LLC boosted its position in Agilon Health by 244.9% during the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock worth $41,000 after buying an additional 6,783 shares during the period.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.